Advisor Group’s Genmab GMAB Stock Holding History

Advisor Group’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$94K	Buy	4,249 +1,906	+81%	+$41.6K	﹤0.01%	2983
2019 Q3	$48K	Buy	+2,343	New	+$46.1K	﹤0.01%	3421

Other funds holding GMAB

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Advisor Group's GMAB Position: Q4 2019 in Review

Advisor Group increased its Genmab (GMAB) stake by 81% in Q4 2019, buying an estimated $41.6K and bringing the position to 4,249 shares worth $94K. The position accounts for ﹤0.01% of the portfolio, ranked #2983.

Advisor Group first reported a position in GMAB in Q3 2019 and has held it in 2 quarters since. 133 funds tracked by Wall St. Rank hold GMAB as of Q4 2019.

Advisor Group held 4,249 shares of Genmab worth $94K as of Q4 2019.
Advisor Group bought 1,906 Genmab shares in Q4 2019, an estimated $41.6K.
Genmab made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2983 holding.
Advisor Group first reported a position in Genmab in Q3 2019 and has held it in 2 quarters since.
133 funds tracked by Wall St. Rank held Genmab as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.